Five Star Equities Issues New Research Reports on CLSN, CNDO, OMCL and XOMA


Follow this company

Companies Mentioned

NASDAQ:CLSN / NASDAQ:CNDO / NASDAQ:OMCL / NASDAQ:XOMA
12/16/2013 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Celsion Corporation (NASDAQ: CLSN) shares jumped 12.32 percent to close at $4.01 a share Friday. The stock traded between $4.00 and $4.59 on volume 3.75 million shares traded. The company announced the presentation of the combined clinical study results from two Phase I trials at the 2013 San Antonio Breast Cancer Conference.

Get more information on Celsion and free access to the in-depth equity report at:  
www.FiveStarEquities.com/CLSN

Coronado Biosciences Inc. (NASDAQ: CNDO) shares surged 20.79 percent to close at $2.15 a share Friday. The stock traded between $2.06 and $2.70 on volume of 19.27 million shares traded. The company reported positive interim data from its recent autism study at a Neuropsychopharmacology meeting. Shares of Coronado Biosciences have fallen approximately 52.0 percent year-to-date.

Get more information on Coronado Biosciences and free access to the in-depth equity report at:  
www.FiveStarEquities.com/CNDO

Omnicell, Inc. (NASDAQ: OMCL) shares spiked 7.94 percent to close at $24.33 a share Friday. The stock traded between $23.42 and $24.51 on volume 587,998 shares traded. B. Riley has recently upgraded its rating on the company to “buy” from "neutral". Shares of Omnicell have gained approximately 63.0 percent year-to-date.

Get more information on Omnicell and free access to the in-depth equity report at:  
www.FiveStarEquities.com/OMCL

XOMA Corp. (NASDAQ: XOMA) shares declined 6.89 percent to close at $5.27 a share Friday. The stock traded between $5.24 and $5.48 on volume 7.78 million shares traded. The company announced the pricing of a proposed public offering of 9.5 million shares of its common stock at a price of $5.25 per share.

Get more information on XOMA and free access to the in-depth equity report at:  
www.FiveStarEquities.com/XOMA

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:            
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *